GAITHERSBURG, Md. (AP) _ Novavax Inc. (NVAX) on Monday reported a loss of $57.1 million in its fourth quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of 21 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
The vaccine maker posted revenue of $5.4 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $4.6 million.
For the year, the company reported that its loss widened to $280 million, or $1.03 per share. Revenue was reported as $15.4 million.
In the final minutes of trading on Monday, the company's shares hit $1.63. A year ago, they were trading at $4.59.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVAX at https://www.zacks.com/ap/NVAX
Keywords: Novavax, Earnings Report